Biomarkers in Medicine

Biomarkers in Medicine 由 Future Medicine Ltd. 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Inflammatory Biomarkers in Disease Prognosis、MicroRNA in disease regulation、Cancer-related molecular mechanisms research 等主题的论文，这 3 个主题约占 23.9%，主导子领域为 Cancer Research。（根据 OpenAlex 主题统计与中科院分区数据生成）

Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory. Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice. As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications. Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest. Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.

来源：LetPub

研究方向（LetPub）：医学-医学：研究与实验

中科院期刊分区表

数据库收录

SCIEScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

2.37LetPub · 2026-09-13

CiteScore 2026-06

3.2LetPub · 2026-09-13

SJR 2026-06

0.58LetPub · 2026-09-13

SNIP 2026-06

0.62LetPub · 2026-09-13

h-index

37LetPub · 2026-09-13

h-index

73OpenAlex · 2026-10-01

i10-index

993OpenAlex · 2026-10-01

两年平均被引

2.16OpenAlex · 2026-10-01

自引率

4.8%LetPub · 2026-09-13

Gold OA 文章占比

4.08%LetPub · 2026-09-13

发文规模

年文章数

130LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

较慢,6-12周LetPub · 2026-09-13

平均录用比例（社区反馈）

一般LetPub · 2026-09-13

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

尚未从任何来源获得费用信息，请以期刊官网为准。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

出版商

Future Medicine Ltd.

出版国家或地区

ENGLAND

出版语言

English

出版周期

Bimonthly

创刊年份

2007

ISSN

1752-0363

电子版 ISSN

1752-0371

官方链接

• 期刊主页 ↗LetPub
• 投稿系统 ↗LetPub